Eton Pharmaceuticals, Inc. (ETON)

Eton Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	25.94	14.94	21.39	16.31	14.41
Cash & Short-Term Investments	25.94	14.94	21.39	16.31	14.41
Cash Growth	73.69%	-30.17%	31.17%	13.18%	-32.35%
Accounts Receivable	11.76	5.36	3.41	1.85	5.47
Inventory	15.42	15.23	0.91	0.56	0.55
Other Current Assets	7.46	5.49	1.13	1.29	3.18
Total Current Assets	60.58	41.02	26.84	20	23.6
Net Property, Plant & Equipment	0.64	0.21	0.15	0.26	0.22
Other Intangible Assets	30.88	34.88	4.74	4.75	3.62
Other Long-Term Assets	0.02	0.01	0.01	0.01	0.02
Total Assets	92.11	76.12	31.74	25.03	27.47
Accounts Payable	10.98	4.17	1.85	1.77	1.77
Accrued Expenses	18.73	15.78	9.01	3.66	1.37
Short-Term Debt	8.79	-	-	-	-
Current Portion of Long-Term Debt	-	-	5.38	1.03	1.42
Total Current Liabilities	38.49	19.95	16.24	6.46	4.56
Long-Term Debt	21.77	29.81	-	5.38	5.26
Long-Term Leases	0.46	0.11	0.02	0.11	0.02
Other Long-Term Liabilities	5.24	1.83	-	-	-
Total Long-Term Liabilities	27.47	31.75	0.02	5.49	5.28
Total Liabilities	65.96	51.7	16.26	11.95	9.84
Common Stock	0.03	0.03	0.03	0.03	0.03
Additional Paid-in Capital	138.62	132.29	119.52	116.19	111.72
Retained Earnings	-112.49	-107.89	-104.07	-103.13	-94.11
Shareholders' Equity	26.15	24.43	15.48	13.08	17.63
Total Liabilities & Equity	92.11	76.12	31.74	25.03	27.47
Total Debt	31.02	29.92	5.4	6.52	6.7
Net Cash (Debt)	-5.08	-14.98	15.99	9.78	7.71
Net Cash Growth	-	-	63.44%	26.85%	-45.52%
Net Cash Per Share	-0.19	-0.58	0.62	0.39	0.31
Book Value	26.15	24.43	15.48	13.08	17.63
Book Value Per Share	0.97	0.94	0.60	0.52	0.70
Tangible Book Value	-4.72	-10.45	10.74	8.32	14.01
Tangible Book Value Per Share	-0.18	-0.40	0.42	0.33	0.56

Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q